Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MEDSIGN INTERNATIONAL CORPORATION via THORNROSE VENTURES
2026 · third_quarter · RR
Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.
Source: Senate LDA
| 1 |
| 2026 |
| PRESTIGE WOUND SOLUTIONS AND PRESTIGE FOOT AND ANKLE CENTER | 1 | 2026 |
| VALKOR LLC | 1 | 2026 |
| WORLD FOOD BANK GROUP | 1 | 2026 |
Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.
Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.
Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.
Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.
Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.
PATRIOT NICKEL CORP via THORNROSE VENTURES
2026 · third_quarter · RR
Lobbying related to domestic critical mineral supply chains, specifically the permitting, extraction, and processing of nickel for use in advanced batteries and defense applications. Specific issues include:Advocating for efficient federal mine permitting processes under the National Environmental Policy Act (NEPA) and Clean Water Act. Issues related to Department of Energy (DOE) grant programs and Defense Production Act (DPA) Title III funding for domestic critical mineral projects.
Lobbying related to domestic critical mineral supply chains, specifically the permitting, extraction, and processing of nickel for use in advanced batteries and defense applications. Specific issues include:Advocating for efficient federal mine permitting processes under the National Environmental Policy Act (NEPA) and Clean Water Act. Issues related to Department of Energy (DOE) grant programs and Defense Production Act (DPA) Title III funding for domestic critical mineral projects.
Lobbying related to domestic critical mineral supply chains, specifically the permitting, extraction, and processing of nickel for use in advanced batteries and defense applications. Specific issues include:Advocating for efficient federal mine permitting processes under the National Environmental Policy Act (NEPA) and Clean Water Act. Issues related to Department of Energy (DOE) grant programs and Defense Production Act (DPA) Title III funding for domestic critical mineral projects.
Lobbying related to domestic critical mineral supply chains, specifically the permitting, extraction, and processing of nickel for use in advanced batteries and defense applications. Specific issues include:Advocating for efficient federal mine permitting processes under the National Environmental Policy Act (NEPA) and Clean Water Act. Issues related to Department of Energy (DOE) grant programs and Defense Production Act (DPA) Title III funding for domestic critical mineral projects.
Lobbying related to domestic critical mineral supply chains, specifically the permitting, extraction, and processing of nickel for use in advanced batteries and defense applications. Specific issues include:Advocating for efficient federal mine permitting processes under the National Environmental Policy Act (NEPA) and Clean Water Act. Issues related to Department of Energy (DOE) grant programs and Defense Production Act (DPA) Title III funding for domestic critical mineral projects.
Lobbying related to domestic critical mineral supply chains, specifically the permitting, extraction, and processing of nickel for use in advanced batteries and defense applications. Specific issues include:Advocating for efficient federal mine permitting processes under the National Environmental Policy Act (NEPA) and Clean Water Act. Issues related to Department of Energy (DOE) grant programs and Defense Production Act (DPA) Title III funding for domestic critical mineral projects.
Lobbying related to domestic critical mineral supply chains, specifically the permitting, extraction, and processing of nickel for use in advanced batteries and defense applications. Specific issues include:Advocating for efficient federal mine permitting processes under the National Environmental Policy Act (NEPA) and Clean Water Act. Issues related to Department of Energy (DOE) grant programs and Defense Production Act (DPA) Title III funding for domestic critical mineral projects.
WORLD FOOD BANK GROUP via THORNROSE VENTURES
2026 · third_quarter · RR
Private Public partnerships related to food security, agriculture, strategic food reserves, disaster response, humanitarian assistance, nutrition programs, farmer support, and food-supply-chain resilience.
Private Public partnerships related to food security, agriculture, strategic food reserves, disaster response, humanitarian assistance, nutrition programs, farmer support, and food-supply-chain resilience.
Private Public partnerships related to food security, agriculture, strategic food reserves, disaster response, humanitarian assistance, nutrition programs, farmer support, and food-supply-chain resilience.
Private Public partnerships related to food security, agriculture, strategic food reserves, disaster response, humanitarian assistance, nutrition programs, farmer support, and food-supply-chain resilience.
Private Public partnerships related to food security, agriculture, strategic food reserves, disaster response, humanitarian assistance, nutrition programs, farmer support, and food-supply-chain resilience.
Private Public partnerships related to food security, agriculture, strategic food reserves, disaster response, humanitarian assistance, nutrition programs, farmer support, and food-supply-chain resilience.
Private Public partnerships related to food security, agriculture, strategic food reserves, disaster response, humanitarian assistance, nutrition programs, farmer support, and food-supply-chain resilience.
ACESO PLASMA, INC via THORNROSE VENTURES
2026 · third_quarter · RR
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
PRESTIGE WOUND SOLUTIONS AND PRESTIGE FOOT AND ANKLE CENTER via THORNROSE VENTURES
2026 · third_quarter · RR
Federal policies, reimbursement, coverage, and agency actions related to Medicare wound-care services, mobile and in-home wound care, advanced wound therapies, diabetic wounds, limb preservation, and access to specialized wound treatment.
Federal policies, reimbursement, coverage, and agency actions related to Medicare wound-care services, mobile and in-home wound care, advanced wound therapies, diabetic wounds, limb preservation, and access to specialized wound treatment.
Federal policies, reimbursement, coverage, and agency actions related to Medicare wound-care services, mobile and in-home wound care, advanced wound therapies, diabetic wounds, limb preservation, and access to specialized wound treatment.
Federal policies, reimbursement, coverage, and agency actions related to Medicare wound-care services, mobile and in-home wound care, advanced wound therapies, diabetic wounds, limb preservation, and access to specialized wound treatment.
MINO, LLC via THORNROSE VENTURES
2026 · third_quarter · RR
Federal policies and agency actions related to peptide therapies, precision medicine, physician-supervised access, pharmaceutical quality and safety, drug compounding, clinical research, and healthcare innovation.
Federal policies and agency actions related to peptide therapies, precision medicine, physician-supervised access, pharmaceutical quality and safety, drug compounding, clinical research, and healthcare innovation.
Federal policies and agency actions related to peptide therapies, precision medicine, physician-supervised access, pharmaceutical quality and safety, drug compounding, clinical research, and healthcare innovation.
VALKOR LLC via THORNROSE VENTURES
2026 · third_quarter · RR
Federal policies, programs, funding, permitting, and agency actions related to oil, gas, mining, low-carbon fuels, carbon capture, mineral recovery, environmental remediation, and energy infrastructure.
Federal policies, programs, funding, permitting, and agency actions related to oil, gas, mining, low-carbon fuels, carbon capture, mineral recovery, environmental remediation, and energy infrastructure.
Federal policies, programs, funding, permitting, and agency actions related to oil, gas, mining, low-carbon fuels, carbon capture, mineral recovery, environmental remediation, and energy infrastructure.
MONTLARGO ENERGY INC via THORNROSE VENTURES
2026 · third_quarter · RR
Federal policies, programs, funding, permitting, and agency actions related to critical-mineral exploration, mining, processing, refining, renewable energy, and domestic supply-chain development, including magnesium, copper, gold, rare-earth elements, and platinum-group metals.
Federal policies, programs, funding, permitting, and agency actions related to critical-mineral exploration, mining, processing, refining, renewable energy, and domestic supply-chain development, including magnesium, copper, gold, rare-earth elements, and platinum-group metals.
Federal policies, programs, funding, permitting, and agency actions related to critical-mineral exploration, mining, processing, refining, renewable energy, and domestic supply-chain development, including magnesium, copper, gold, rare-earth elements, and platinum-group metals.
DNA HIVE LLC via THORNROSE VENTURES
2026 · third_quarter · RR
Federal policies, programs, funding, and agency actions related to healthcare, biomedical research, health information technology, data analytics, artificial intelligence, and emerging technologies.
Federal policies, programs, funding, and agency actions related to healthcare, biomedical research, health information technology, data analytics, artificial intelligence, and emerging technologies.
Federal policies, programs, funding, and agency actions related to healthcare, biomedical research, health information technology, data analytics, artificial intelligence, and emerging technologies.
ENERGY EIGHT LLC via THORNROSE VENTURES
2026 · third_quarter · RR
Advocate on issues related to energy, passive energy solutions, and power quality.
Federal policies and agency actions related to peptide therapies, precision medicine, physician-supervised access, pharmaceutical quality and safety, drug compounding, clinical research, and healthcare innovation.
Federal policies and agency actions related to peptide therapies, precision medicine, physician-supervised access, pharmaceutical quality and safety, drug compounding, clinical research, and healthcare innovation.
Federal policies, programs, funding, permitting, and agency actions related to oil, gas, mining, low-carbon fuels, carbon capture, mineral recovery, environmental remediation, and energy infrastructure.
Federal policies, programs, funding, permitting, and agency actions related to oil, gas, mining, low-carbon fuels, carbon capture, mineral recovery, environmental remediation, and energy infrastructure.
Federal policies, programs, funding, permitting, and agency actions related to oil, gas, mining, low-carbon fuels, carbon capture, mineral recovery, environmental remediation, and energy infrastructure.
Federal policies, programs, funding, permitting, and agency actions related to oil, gas, mining, low-carbon fuels, carbon capture, mineral recovery, environmental remediation, and energy infrastructure.
Federal policies, programs, funding, permitting, and agency actions related to oil, gas, mining, low-carbon fuels, carbon capture, mineral recovery, environmental remediation, and energy infrastructure.
Federal policies, programs, funding, permitting, and agency actions related to critical-mineral exploration, mining, processing, refining, renewable energy, and domestic supply-chain development, including magnesium, copper, gold, rare-earth elements, and platinum-group metals.
Federal policies, programs, funding, permitting, and agency actions related to critical-mineral exploration, mining, processing, refining, renewable energy, and domestic supply-chain development, including magnesium, copper, gold, rare-earth elements, and platinum-group metals.
Federal policies, programs, funding, permitting, and agency actions related to critical-mineral exploration, mining, processing, refining, renewable energy, and domestic supply-chain development, including magnesium, copper, gold, rare-earth elements, and platinum-group metals.
Federal policies, programs, funding, and agency actions related to healthcare, biomedical research, health information technology, data analytics, artificial intelligence, and emerging technologies.